Robotic Rehab Devices in California

Ekso Bionics is a publicly traded leader in wearable exoskeleton technology, founded in 2005 by UC Berkeley experts and headquartered in San Rafael, California. The company develops FDA-cleared robotic exoskeletons for clinical and home rehabilitation, targeting patients with spinal cord injury, stroke, brain injury, and multiple sclerosis. Its healthcare portfolio includes the EksoNR (inpatient rehabilitation), Ekso Indego Therapy (outpatient therapy), and Ekso Indego Personal (home/community use). All products feature Variable Assist technology that adapts power delivery to enhance mobility and functional independence. With 500+ rehabilitation centers worldwide and Medicare coverage eligibility, Ekso Bionics serves hospitals, outpatient facilities, and individuals seeking mobility restoration and neurological recovery support.

Cosmo Robotics Co., Ltd is a South Korean wearable robotics manufacturer specializing in exoskeleton suits and wearable robotic systems for rehabilitation, mobility assistance, and industrial applications. The company develops and manufactures proprietary wearable robot technology domestically and exports globally. Core product lines include the Exoatlet series (EAM, EA2 Pro), pediatric systems (Bambini Kids, Bambini Teens), personal/geriatric assistance (COSuit, EA Personal), and industrial back-support exoskeletons (COSaver Back). The company emphasizes intention recognition technology, natural gait pattern realization, free walking ability expansion, bio-signal-based walking evaluation, and integrated data collection and analysis capabilities. Products address rehabilitation needs across age groups from infants through elderly populations, as well as occupational ergonomics and daily living support. Manufacturing is Korea-based with international distribution networks. The company maintains patents on core exoskeleton technologies and certifications relevant to medical device and wearable robot classifications. Cosmo Robotics positions itself as a leader in the global wearable robotics market with applications spanning clinical rehabilitation, home care, and industrial workplace safety.

Neurolutions develops the IpsiHand Upper Extremity Rehabilitation System, an FDA-cleared brain-computer interface (BCI) device for home-based motor recovery therapy in chronic stroke survivors. The non-invasive system comprises an EEG headset that captures motor intention signals from the unimpaired brain hemisphere, a powered wireless handpiece that moves the affected hand, and a tablet interface for guided treatment and progress tracking. Clinical data shows approximately 70% of trial participants improved arm and hand function, with an average 8.1-point improvement on the Fugl-Meyer Assessment within 12 weeks. IpsiHand enables patients to overcome recovery plateaus years or decades post-stroke through autonomous home therapy, with broad insurance coverage including Medicare and VA benefits.